↓ Read PDF
01 · ABSTRACT

Abstract

Background: The existence of patients with Hepatitis C virus who were diagnosed but unlinked to care (DBUC) hinders the Hepatitis C elimination. The objectives were to present the results of the ReLink-C strategy in three Spanish hospitals and analyse its efficiency for both patients with positive viral load testing (full diagnosis) and with HCV antibodies, but without positive viral load testing (partial diagnosis); and partial diagnosis only.

Methods: The strategy was divided in two phases: Phase I, DBUC patients with complete or partial diagnosis without follow-up from Microbiology unit were searched and identified; and Phase II, missing patients were contacted by telephone and referred to Hepatology for further treatment. In addition, the characteristics (age, gender, country of origin and fibrosis status) of the lost and treated patients were collected.

Results: The three hospitals identified 3,444 patients to search for retrieval, 1,538 (45%) with full diagnosis and 1,906 (55%) partial diagnosis. Overall, about 35% (1,221/3,444) were DBUC and the ReLink-C strategy successfully localised 903 patients, of which 493 patients were linkage to care and 273 were treated. The ReLink-C strategy (full and partial diagnosis) compared to no intervention showed a reduction in liver and mortality complications (range 22-29%) with an incremental cost-utility ratio of €8,958/patient, and in case of partial diagnosis of €9,396/patient.

Conclusions: The Relink-C active search strategy enabled the retrieval and treatment of a significant number of diagnosed hepatitis C cases that would not have been detected in clinical practice. It was cost-effective for both (full and partial diagnosis) and partial diagnosis only, being in line with the 2030 hepatitis C elimination targets.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 12 No 12 (2024): Vol.12 Issue 12 December 2024
SectionResearch Articles
Published24 December 2024
DOI10.18103/mra.v12i12.6149
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

VA

Victoria Aguilera

Hepatology and Liver Transplant Unit, La Fe Universitary and Politécnic Hospital, Valencia, Spain. ; Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain.; CIBERehd, Faculty of Medicine, Valencia University, Valencia, Spain.

RG

Rocío González-Grande

Digestive System Unit. Málaga Regional University Hospital, Málaga, Spain. ;.Instituto de Investigación Biomédica de Málaga (IBIMA)

MP

María-José Pena

Microbiology Unit, Gran Canaria Doctor Negrín University Hospital, Las Palmas, Spain.

AB

Ariadna Bono

La Fe Universitary and Politécnic Hospital, Valencia, Spain.

RG

Rafael Granados

Infectious Diseases Unit. Gran Canaria Doctor Negrín University Hospital, Las Palmas, Spain.

MJ

Miguel Jiménez-Pérez

Digestive System Unit. Málaga Regional University Hospital, Málaga, Spain.

MS

Miriam Serrano

Specialist in Internal Medicine. Gran Canaria Doctor Negrín University Hospital, Las Palmas, Spain.

NE

Nataly Espinoza-Cámac

Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.

RD

Raquel Domínguez-Hernández

Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗